Connection

Allen Kaplan to Basophils

This is a "connection" page, showing publications Allen Kaplan has written about Basophils.
Connection Strength

4.216
  1. Diagnosis, pathogenesis, and treatment of chronic spontaneous urticaria. Allergy Asthma Proc. 2018 May 01; 39(3):184-190.
    View in: PubMed
    Score: 0.587
  2. Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol. 2008 Sep; 122(3):569-73.
    View in: PubMed
    Score: 0.300
  3. IL3 effect on basophils histamine release upon stimulation with chronic urticaria sera. Allergy. 2003 Aug; 58(8):802-7.
    View in: PubMed
    Score: 0.211
  4. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol. 2002 Apr; 109(4):694-700.
    View in: PubMed
    Score: 0.192
  5. A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol. 2002 Jan; 109(1):114-8.
    View in: PubMed
    Score: 0.189
  6. The Pathogenesis of Chronic Spontaneous Urticaria: The Role of Infiltrating Cells. J Allergy Clin Immunol Pract. 2021 06; 9(6):2195-2208.
    View in: PubMed
    Score: 0.180
  7. Basophil histamine release in patients with chronic spontaneous urticaria: Optimize or minimize. J Allergy Clin Immunol. 2019 08; 144(2):622-623.
    View in: PubMed
    Score: 0.158
  8. An IgE-dependent histamine-releasing factor (HRF) identical to a previously described human protein (P23) Allergy. 1998 Jul; 53(7):631-2.
    View in: PubMed
    Score: 0.148
  9. Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria. Allergy. 2017 Apr; 72(4):519-533.
    View in: PubMed
    Score: 0.134
  10. Relationship of histamine-releasing factors and histamine-releasing inhibitory factors to chemokine group of cytokine. Allergy Asthma Proc. 1996 Jan-Feb; 17(1):5-11.
    View in: PubMed
    Score: 0.125
  11. Chemokines and the allergic response. Exp Dermatol. 1995 Aug; 4(4 Pt 2):260-5.
    View in: PubMed
    Score: 0.121
  12. Chemokines of the alpha, beta-subclass inhibit human basophils' responsiveness to monocyte chemotactic and activating factor/monocyte chemoattractant protein-1. J Allergy Clin Immunol. 1995 Feb; 95(2):574-86.
    View in: PubMed
    Score: 0.117
  13. Chemokines as allergic mediators--relationship to histamine-releasing factors. Allergy. 1994 Aug; 49(7):495-501.
    View in: PubMed
    Score: 0.113
  14. Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family. J Immunol. 1993 Mar 01; 150(5):1932-43.
    View in: PubMed
    Score: 0.103
  15. RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils. J Immunol. 1992 Jul 15; 149(2):636-42.
    View in: PubMed
    Score: 0.098
  16. Connective tissue-activating peptide-III and its derivative, neutrophil-activating peptide-2, release histamine from human basophils. J Allergy Clin Immunol. 1992 Mar; 89(3):666-72.
    View in: PubMed
    Score: 0.096
  17. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils. J Exp Med. 1992 Feb 01; 175(2):489-93.
    View in: PubMed
    Score: 0.095
  18. Cytokine stimulation of human basophil histamine release. Immunol Ser. 1992; 57:573-86.
    View in: PubMed
    Score: 0.095
  19. IL-8 inhibits histamine release from human basophils induced by histamine-releasing factors, connective tissue activating peptide III, and IL-3. J Immunol. 1991 Sep 15; 147(6):1920-4.
    View in: PubMed
    Score: 0.093
  20. Release of elastase from purified human lung mast cells and basophils. Identification as a Hageman factor cleaving enzyme. Inflammation. 1989 Jun; 13(3):295-308.
    View in: PubMed
    Score: 0.079
  21. Pathogenesis of chronic urticaria. Clin Exp Allergy. 2009 Jun; 39(6):777-87.
    View in: PubMed
    Score: 0.078
  22. Recombinant human interleukin-1 beta causes histamine release from human basophils. J Allergy Clin Immunol. 1988 Aug; 82(2):218-23.
    View in: PubMed
    Score: 0.075
  23. Human recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3 cause basophil histamine release. J Clin Invest. 1988 Jul; 82(1):17-20.
    View in: PubMed
    Score: 0.074
  24. Basophil secretion in chronic urticaria: autoantibody-dependent or not? J Allergy Clin Immunol. 2007 Sep; 120(3):729-30.
    View in: PubMed
    Score: 0.069
  25. Chronic urticaria: what is new, where are we headed. Allergol Immunopathol (Madr). 2007 Mar-Apr; 35(2):57-61.
    View in: PubMed
    Score: 0.068
  26. Effects of calcineurin inhibitors on an in vitro assay for chronic urticaria. Clin Exp Allergy. 2005 May; 35(5):554-9.
    View in: PubMed
    Score: 0.060
  27. Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria. J Allergy Clin Immunol. 2005 Apr; 115(4):815-21.
    View in: PubMed
    Score: 0.059
  28. Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli. Clin Exp Allergy. 2005 Apr; 35(4):456-60.
    View in: PubMed
    Score: 0.059
  29. Chemokines, chemokine receptors and allergy. Int Arch Allergy Immunol. 2001 Apr; 124(4):423-31.
    View in: PubMed
    Score: 0.045
  30. Comparative studies of functional and binding assays for IgG anti-Fc(epsilon)RIalpha (alpha-subunit) in chronic urticaria. J Allergy Clin Immunol. 1998 May; 101(5):672-6.
    View in: PubMed
    Score: 0.037
  31. Chemokines and the late-phase reaction. Allergy. 1998; 53(45 Suppl):27-32.
    View in: PubMed
    Score: 0.036
  32. Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol. 1997 Apr; 99(4):461-5.
    View in: PubMed
    Score: 0.034
  33. Mediator release from basophil granulocytes in chronic myelogenous leukemia. J Allergy Clin Immunol. 1976 Dec; 58(6):623-34.
    View in: PubMed
    Score: 0.033
  34. Chemokines in seasonal allergic rhinitis. J Allergy Clin Immunol. 1996 Jan; 97(1 Pt 1):104-12.
    View in: PubMed
    Score: 0.031
  35. Histamine releasing factors. Clin Exp Allergy. 1991 Jan; 21 Suppl 1:8-16.
    View in: PubMed
    Score: 0.022
  36. Histamine-releasing factors. Int Arch Allergy Appl Immunol. 1991; 94(1-4):148-53.
    View in: PubMed
    Score: 0.022
  37. Histamine releasing factors and cytokine-dependent activation of basophils and mast cells. Adv Immunol. 1991; 50:237-60.
    View in: PubMed
    Score: 0.022
  38. Relationship of one form of human histamine-releasing factor to connective tissue activating peptide-III. J Clin Invest. 1990 May; 85(5):1516-21.
    View in: PubMed
    Score: 0.021
  39. Neutrophils and mast cells. Comparison of neutrophil-derived histamine-releasing activity with other histamine-releasing factors. J Immunol. 1988 Nov 15; 141(10):3575-83.
    View in: PubMed
    Score: 0.019
  40. Responsiveness to human mononuclear cell-derived histamine-releasing factor. Studies of allergic status and the role of IgE. J Immunol. 1988 Oct 15; 141(8):2688-92.
    View in: PubMed
    Score: 0.019
  41. Anti-IgE autoantibodies in systemic lupus erythematosus. Prevalence and biologic activity. Arthritis Rheum. 1988 Aug; 31(8):1000-6.
    View in: PubMed
    Score: 0.019
  42. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol. 1988 Feb; 90(2):213-7.
    View in: PubMed
    Score: 0.018
  43. Mediators of inflammation: an overview. Methods Enzymol. 1988; 163:3-23.
    View in: PubMed
    Score: 0.018
  44. Assessment of histamine release and kinin formation in man: identification of kinin degradation products and characterization of a lymphocyte-dependent histamine releasing factor. Int Arch Allergy Appl Immunol. 1985; 77(1-2):64-8.
    View in: PubMed
    Score: 0.015
  45. Histologic studies of chronic idiopathic urticaria. J Allergy Clin Immunol. 1983 Feb; 71(2):177-83.
    View in: PubMed
    Score: 0.013
  46. Contrast agents and anaphylactic-like reactions. J Allergy Clin Immunol. 1979 Apr; 63(4):225-7.
    View in: PubMed
    Score: 0.010
  47. Effects of PBMC-derived histamine-releasing factors on histamine release from human skin and lung mast cells. Clin Exp Allergy. 1995 Sep; 25(9):890-5.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.